Analyst Ratings For Kura Oncology (NASDAQ:KURA)
Today, Cann reiterated its Buy rating on Kura Oncology (NASDAQ:KURA) with a price target of $30.00.
Some recent analyst ratings include
- 2/16/2018-Cann Reiterated Rating of Buy.
- 12/26/2017-Wedbush initiated coverage with a Buy rating.
- 9/7/2017-Cowen initiated coverage with a Outperform rating.
- 8/10/2017-Leerink Swann Reiterated Rating of Outperform.
Recent Trading Activity for Kura Oncology (NASDAQ:KURA)
Shares of Kura Oncology closed the previous trading session at 22.20 up +1.15 5.46% with 21.399999618530273 shares trading hands.